# Effect of Empagliflozin 10 vs 25 mg on LV Remodeling in Diabetic Patients With Anterior STEMI With Reduced LVEF

> **NCT07169981** · PHASE2 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 200 (actual)

## Conditions studied

- Diabete Mellitus
- Heart Failure
- Remodeling, Left Ventricle

## Interventions

- **DRUG:** Empagliflozin 10 MG [Jardiance]
- **DRUG:** empagliflozin (Jardiance) 25 mg

## Key facts

- **NCT ID:** NCT07169981
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-12
- **Primary completion:** 2025-02-23
- **Final completion:** 2025-06-17
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2025-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07169981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07169981, "Effect of Empagliflozin 10 vs 25 mg on LV Remodeling in Diabetic Patients With Anterior STEMI With Reduced LVEF". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07169981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*